Daptomycin-Vancomycin-Resistant Enterococcus faecium Native Valve Endocarditis: Successfully Treated With Off-Label Quinupristin-Dalfopristin.
Multidrug-resistant enterococcal nosocomial invasive infections are a rising concern faced by the medical community. Not many options are available to treat these highly virulent organisms. Risk factors for developing these highly resistant organisms include prolonged hospital stay, previous antibiotic use, and immunosuppression. In this article, we report a case of daptomycin-resistant enterococcal native infective endocarditis treated with off-label use of quinupristin-dalfopristin.
Temple University/Conemaugh Memorial Medical Center, Johnstown, PA, USA.
Khandakar
K
Hussain
Temple University/Conemaugh Memorial Medical Center, Johnstown, PA, USA.
Saad
S
Ullah
Temple University/Conemaugh Memorial Medical Center, Johnstown, PA, USA.
Hassan
H
Tahir
Temple University/Conemaugh Memorial Medical Center, Johnstown, PA, USA.
Waseem Zaid
WZ
Alkilani
Temple University/Conemaugh Memorial Medical Center, Johnstown, PA, USA.
Muhammad
M
Naeem
Temple University/Conemaugh Memorial Medical Center, Johnstown, PA, USA.
Nagadarshini Ramagiri
NR
Vinod
Temple University/Conemaugh Memorial Medical Center, Johnstown, PA, USA.
Samuel
S
Massoud
Enterococcal faecalis; daptomycin-resistant enterococci; infective endocarditis; multidrug resistance; quinupristin-dalfopristin
Clin Infect Dis. 2000 May;30(5):790-7
10817685
J Antimicrob Chemother. 1997 May;39 Suppl A:145-51
9511079
Expert Rev Anti Infect Ther. 2014 Oct;12(10):1221-36
25199988
Infect Dis Clin North Am. 1993 Mar;7(1):117-33
8463648
Clin Infect Dis. 2001 Dec 1;33(11):1816-23
11668430
Eur Heart J. 2015 Nov 21;36(44):3075-128
26320109
Clin Infect Dis. 2011 Jan 15;52(2):228-34
21288849
N Engl J Med. 2000 Mar 9;342(10):710-21
10706902